These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 11741219)

  • 1. Maturation and growth of renal function: dosing renally cleared drugs in children.
    Hayton WL
    AAPS PharmSci; 2000; 2(1):E3. PubMed ID: 11741219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations.
    Bartelink IH; Rademaker CM; Schobben AF; van den Anker JN
    Clin Pharmacokinet; 2006; 45(11):1077-97. PubMed ID: 17048973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maturation of the glomerular filtration rate in neonates, as reflected by amikacin clearance.
    De Cock RF; Allegaert K; Schreuder MF; Sherwin CM; de Hoog M; van den Anker JN; Danhof M; Knibbe CA
    Clin Pharmacokinet; 2012 Feb; 51(2):105-17. PubMed ID: 22229883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiological modelling of renal drug clearance.
    Janků I
    Eur J Clin Pharmacol; 1993; 44(6):513-9. PubMed ID: 8405004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal physiology in children.
    Roy LP
    Anaesth Intensive Care; 1973 Nov; 1(6):457-61. PubMed ID: 4585772
    [No Abstract]   [Full Text] [Related]  

  • 6. The Influence of Drug Properties and Ontogeny of Transporters on Pediatric Renal Clearance through Glomerular Filtration and Active Secretion: a Simulation-Based Study.
    Cristea S; Krekels EHJ; Rostami-Hodjegan A; Allegaert K; Knibbe CAJ
    AAPS J; 2020 Jun; 22(4):87. PubMed ID: 32566984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Predictive Value of Glomerular Filtration Rate-Based Scaling of Pediatric Clearance and Doses for Drugs Eliminated by Glomerular Filtration with Varying Protein-Binding Properties.
    Cristea S; Krekels EHJ; Allegaert K; Knibbe CAJ
    Clin Pharmacokinet; 2020 Oct; 59(10):1291-1301. PubMed ID: 32314184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric Renal Ontogeny and Applications in Drug Development.
    Zhang Y; Mehta N; Muhari-Stark E; Burckart GJ; van den Anker J; Wang J
    J Clin Pharmacol; 2019 Sep; 59 Suppl 1():S9-S20. PubMed ID: 31502684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creatinine-Based Renal Function Assessment in Pediatric Drug Development: An Analysis Using Clinical Data for Renally Eliminated Drugs.
    Zhang Y; Sherwin CM; Gonzalez D; Zhang Q; Khurana M; Fisher J; Burckart GJ; Wang Y; Yao LP; Ganley CJ; Wang J
    Clin Pharmacol Ther; 2021 Jan; 109(1):263-269. PubMed ID: 32696977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ontogeny of drug elimination by the human kidney.
    Chen N; Aleksa K; Woodland C; Rieder M; Koren G
    Pediatr Nephrol; 2006 Feb; 21(2):160-8. PubMed ID: 16331517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous renal transport of free amino acids in infancy and childhood.
    Brodehl J; Gellissen K
    Pediatrics; 1968 Sep; 42(3):395-404. PubMed ID: 5677481
    [No Abstract]   [Full Text] [Related]  

  • 12. Prediction of drug clearance in children.
    Foissac F; Bouazza N; Valade E; De Sousa Mendes M; Fauchet F; Benaboud S; Hirt D; Tréluyer JM; Urien S
    J Clin Pharmacol; 2015 Jul; 55(7):739-47. PubMed ID: 25721251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transitional nephrology.
    Stewart CL; Jose PA
    Urol Clin North Am; 1985 Feb; 12(1):143-49. PubMed ID: 3883620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allometric Scaling of Clearance in Paediatric Patients: When Does the Magic of 0.75 Fade?
    Calvier EA; Krekels EH; Välitalo PA; Rostami-Hodjegan A; Tibboel D; Danhof M; Knibbe CA
    Clin Pharmacokinet; 2017 Mar; 56(3):273-285. PubMed ID: 27510367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive Performance of Physiologically Based Pharmacokinetic and Population Pharmacokinetic Modeling of Renally Cleared Drugs in Children.
    Zhou W; Johnson TN; Xu H; Cheung S; Bui KH; Li J; Al-Huniti N; Zhou D
    CPT Pharmacometrics Syst Pharmacol; 2016 Sep; 5(9):475-83. PubMed ID: 27566992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of carboplatin, etoposide and melphalan in children: a re-evaluation of paediatric dosing formulas for carboplatin in patients with normal or mild impairment of renal function.
    Duong JK; Veal GJ; Nath CE; Shaw PJ; Errington J; Ladenstein R; Boddy AV
    Br J Clin Pharmacol; 2019 Jan; 85(1):136-146. PubMed ID: 30261554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic variability in the adolescent: implications of body size and organ function for dosage regimen design.
    Rodman JH
    J Adolesc Health; 1994 Dec; 15(8):654-62. PubMed ID: 7696286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human renal function maturation: a quantitative description using weight and postmenstrual age.
    Rhodin MM; Anderson BJ; Peters AM; Coulthard MG; Wilkins B; Cole M; Chatelut E; Grubb A; Veal GJ; Keir MJ; Holford NH
    Pediatr Nephrol; 2009 Jan; 24(1):67-76. PubMed ID: 18846389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of prenatal glucocorticoids on renal maturation in newborn infants.
    MacKintosh D; Baird-Lambert J; Drage D; Buchanan N
    Dev Pharmacol Ther; 1985; 8(2):107-14. PubMed ID: 3888561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interplay between drugs and the kidney in premature neonates.
    Schreuder MF; Bueters RR; Allegaert K
    Pediatr Nephrol; 2014 Nov; 29(11):2083-91. PubMed ID: 24217783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.